+44 (0) 1223 755950
+1 832 327 7413
Click on the image to see the image legend
Introduction | Mycoplasma pneumoniae is an unusually small Gram negative bacterium responsible for mycoplasma pneumonia. The bacterium is parasitic, relying on its host for the nutrients required for its replication. It also has a number of unusual features that set it aside from other classes of bacterium; it lacks a peptidoglycan cell wall, the TGA codon encodes for tryptophan, and it uses cholesterol to reinforce its single cell membrane. When inhaled in droplets, M. pneumoniae can adhere to the pulmonary ciliated cells, which it uses as a growth surface and a source of nutrients. It normally causes atypical pneumonia symptoms, with a slower-normal-disease progression. As it lacks a cell wall, penicillins and other β-lactams are ineffective against this pathogen; infections are typically treated using macrolides, fluoroquinolones, and tetracyclines. |
Target | Mycoplasma pneumoniae IgG (M. pneumoniae IgG) |
Reactivity | Human |
Tested Applications | ELISA |
Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
Storage | Shipped at 4 °C. Upon receipt, store the kit according to the storage instruction in the kit's manual. |
Validity | The validity for this kit is at least 6 months. Up to 12 months validity can be provided on request. |
Stability | The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5% within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout. |
Standard Form | Lyophilized |
Detection Method | Colorimetric |
Assay Type | Indirect |
Assay Data | Qualitative |
Sample Type | Serum |
Availability | Shipped within 5-12 working days. |
Note | This product is for research use only. Please note that our ELISA and CLIA kits are optimised for detection of native samples, rather than recombinant proteins. We are unable to guarantee detection of recombinant proteins, as they may have different sequences or tertiary structures to the native protein. |